№ files_lp_4_process_1_27758
File format: docx
Character count: 3945
File size: 24 KB
Official SEC filing reporting the acquisition and disposal of securities by a company officer under federal ownership disclosure requirements.
Year:
2026
Region / City:
Washington, D.C., United States
Subject:
Securities Transactions and Ownership Reporting
Document Type:
Regulatory Filing
Agency:
United States Securities and Exchange Commission
Filing Person:
Chauche Thierry
Position:
Chief Financial Officer
Issuer:
Sagimet Biosciences Inc.
Ticker Symbol:
SGMT
Transaction Date:
02/10/2026
Securities Involved:
Series A Common Stock
Transaction Type:
Disposal to cover tax withholding
Filing Date:
02/12/2026
Legal Reference:
Section 16(a) of the Securities Exchange Act of 1934
Price: 8 / 10 USD
The file will be delivered to the email address provided at checkout within 12 hours.
The file will be delivered to the email address provided at checkout within 12 hours.
Don’t have cryptocurrency yet?
You can still complete your purchase in a few minutes:- Buy Crypto in a trusted app (Coinbase, Kraken, Cash App or any similar service).
- In the app, tap Send.
- Select network, paste our wallet address.
- Send the exact amount shown above.
The final amount may vary slightly depending on the payment method.
The file will be sent to the email address provided at checkout within 24 hours.
The product description is provided for reference. Actual content and formatting may differ slightly.
Year:
2020
Region / City:
West Lafayette, IN
Subject:
Biochemistry, Molecular Biosciences
Document Type:
Syllabus
Institution:
Purdue University
Author:
Dr. Pete E. Pascuzzi
Target Audience:
Students enrolled in BCHM 421R
Period of Validity:
Fall 2020
Date of Approval:
Not specified
Date of Changes:
Not specified
Year:
2025
Organization:
Department of Agriculture, Environment and Rural Affairs (DAERA)
Region:
Northern Ireland, UK
Document type:
Application form
Target audience:
Applicants for AFBI Board positions
Submission deadline:
6 March 2025
Contact email:
[email protected]
Postal address:
Public Appointments Unit (PAU), Jubilee House, 111 Ballykelly Road, Ballykelly, BT49 9HP
Data protection officer:
[email protected]
Retention period:
7 years for successful applicants, 3 years for unsuccessful applicants
Equal opportunities monitoring:
Included
Guaranteed Interview Scheme:
Applies for applicants with disability
Format requirements:
Typewritten Arial 12 or legible handwritten block capitals
Institution:
Stockholm University
Department:
Department of Molecular Biosciences, The Wenner-Gren Institute (MBW)
Type of document:
Vacancy announcement
Position:
Doctoral student (PhD student)
Field:
Molecular Biosciences
Employment form:
Fixed-term doctoral studentship
Legal framework:
Higher Education Ordinance (1993:100), Chapter 5
Employment duration:
Equivalent to four years of full-time doctoral education
Work duties:
Doctoral education with up to 20% departmental duties
Selection criteria:
Academic qualifications, research capacity, analytical and creative thinking, initiative, independence, collaboration skills, proficiency in Swedish and English
Application system:
Stockholm University recruitment system
Contact:
Subject representative / Professor (to be specified)
Union representatives:
Saco-S; Fackförbundet ST/OFR; SEKO
Closing date:
To be specified
Year:
2024-25
Region / City:
Birmingham
Theme:
Postgraduate Exchange Program
Document Type:
Guide
Organization / Institution:
University of Birmingham
Author:
School of Biosciences
Target Audience:
Incoming Postgraduate Exchange Students
Period of Validity:
2024-25
Approval Date:
2024
Date of Changes:
N/A
Context:
This guide provides incoming postgraduate exchange students with detailed information on module choices available in the School of Biosciences for the 2024-25 academic year.
Year:
2026
Company:
Arcadia Biosciences, Inc.
Type of Document:
Prospectus
Securities Type:
Common Stock
Number of Shares:
1,673,792
Offering Method:
Resale by Selling Stockholders
Stock Exchange Listing:
Nasdaq Capital Market
Ticker Symbol:
RKDA
Last Reported Price:
$2.27 per share
Registration Statement Number:
333-292993
Filing Date:
February 10, 2026
Relevant Legislation:
Securities Act of 1933, Securities Exchange Act of 1934
Audience:
Potential investors
Period of Reference:
Private placement completed January 12, 2026
Risk Disclosure:
High degree of investment risk described in Risk Factors section
Year:
2026
Company / Organization:
Precision BioSciences Inc
Person Reporting:
Michael Amoroso
Position:
President and CEO
Type of Document:
SEC Form 4
Subject:
Changes in beneficial ownership of common stock and RSUs
Date of Transactions:
01/20/2026, 01/22/2026
Filing Authority:
United States Securities and Exchange Commission
Method:
Transactions executed under Rule 10b5-1 plan
Number of Shares Affected:
124,463, 161,532, 230,953, 34,799
Transaction Type:
Acquisition and sale of restricted stock units and common stock
Price Range:
$3.97–$4.30
Year:
2024
Region / City:
India
Subject:
Initial Public Offering
Document Type:
Audio Visual Disclosure
Organization / Institution:
Anthem Biosciences Limited
Author:
Anthem Biosciences Limited
Target Audience:
Investors residing outside the United States
Approval Date:
May 24, 2024
Draft Red Herring Prospectus Date:
December 31, 2024
Regulatory Authority:
Securities and Exchange Board of India (SEBI)
Stock Exchanges:
BSE Limited, National Stock Exchange of India Limited
Book Running Lead Managers:
JM Financial Limited, Citigroup Global Markets India Private Limited, J.P. Morgan India Private Limited, Nomura Financial Advisory and Securities (India) Private Limited
Legal Restrictions:
Access restricted in the United States and other jurisdictions where unlawful
Agency:
United States Securities and Exchange Commission
Form number:
Form 25
Document type:
Regulatory filing form
Jurisdiction:
United States
Legal basis:
Securities Exchange Act of 1934
Applicable rules:
Rule 12d2-2 (17 CFR 240.12d2-2); Rule 19d-1 (17 CFR 240.19d-1)
OMB control number:
3235-0080
OMB expiration date:
March 31, 2021
Filing system:
EDGAR
Effective delisting period:
10 days after filing
Effective withdrawal of registration period:
90 days after filing
Revision identifier:
SEC 1654 (03-06)
Year:
20__
Jurisdiction:
State of New York, USA
Document Type:
Bid Bond / Legal Agreement
Issuing Authority:
Office of General Services - Design & Construction
Parties Involved:
Principal (Contractor), Surety Company
Purpose:
Guarantee of contract execution and performance bonds
Notary Public Involvement:
Required for acknowledgment
Legal Reference:
Public Buildings Law, Sub. 3, Sec. 8
Note:
Date issued
Year:
2020
Region / city:
Great Britain
Topic:
Smart Metering, SEC Modifications, Technical Specifications
Document type:
Consultation paper
Organ / institution:
Data and Communications Company (DCC)
Author:
DCC
Target audience:
Industry professionals, technical users of the DUIS and MMC
Period of validity:
Until November 2020
Approval date:
28 April 2020
Amendment date:
Not specified
Date:
1 October 2020
Author:
[email protected]
Classification:
DCC Public
Note:
Region / City
Theme:
DCC User Interface, Smart Metering, SEC Release
Document Type:
Conclusions Document
Year:
2018
Region / city:
New York
Subject:
Earth Science, Geology, Environmental Science
Document Type:
Course Syllabus
Institution:
The City College of New York
Instructor:
Prof. Patricia Kenyon
Target Audience:
Undergraduate students in Earth Science, Geology, EESS, and Architecture majors
Course Duration:
Spring Semester 2018
Approval Date:
Not specified
Date of Changes:
Not specified
Note:
Year
Topic:
Documentary requirements for non-stock, non-profit corporations
Document Type:
Checklist
Year:
2020
Region / City:
Colorado
Subject:
Mental health diversion programs for individuals with low-level criminal offenses
Document Type:
Funding Request
Organization / Institution:
Colorado Judicial Branch
Author:
Kara Martin
Target Audience:
State and local agencies, funding bodies, judicial and mental health professionals
Effective Period:
FY21
Approval Date:
April 28, 2020
Date of Changes:
None
Country:
United States
Issuing authority:
United States Securities and Exchange Commission
Form number:
4
OMB Number:
3235-0287
Legal basis:
Section 16(a) of the Securities Exchange Act of 1934; Section 30(h) of the Investment Company Act of 1940
Type of document:
Regulatory filing
Reporting person:
Garland J. Scott
Issuer:
ALX ONCOLOGY HOLDINGS INC
Ticker symbol:
ALXO
Issuer address:
323 Allerton Avenue, South San Francisco, CA 94080
Date of earliest transaction:
01/20/2026
Date signed:
01/21/2026
Derivative security:
Stock option (right to buy)
Exercise price:
$1.32
Number of shares underlying derivative security:
40,400
Expiration date:
01/19/2036
Vesting terms:
12 equal monthly installments beginning on February 20, 2026
Form:
SEC Form 4
Title:
Statement of Changes in Beneficial Ownership
Filing Authority:
United States Securities and Exchange Commission
Legal Basis:
Section 16(a) of the Securities Exchange Act of 1934; Section 30(h) of the Investment Company Act of 1940
OMB Number:
3235-0287
Reporting Person:
Alana K. Knowles
Reporting Person Address:
5001 Executive Parkway, Suite 200, San Ramon, CA 94583
Issuer:
Chevron Corp
Ticker Symbol:
CVX
Relationship to Issuer:
Officer (Controller)
Date of Earliest Transaction:
January 5, 2026
Date of Signature:
January 7, 2026
Securities Reported:
Common Stock; Non-Qualified Stock Option (Right to Buy)
Transaction Codes:
M (Exercise of Option); S (Sale)
Rule 10b5-1 Plan:
Trading plan adopted February 21, 2025
Signature:
Rose Z. Pierson, Attorney-in-Fact for Alana K. Knowles
Year:
2010
Region / City:
Washington, D.C.
Subject:
Securities Reporting
Document Type:
SEC Filing
Agency / Organization:
United States Securities and Exchange Commission
Author:
Nathan Leight
Target Audience:
Investors, Financial Analysts, Legal Professionals
Period of Action:
March 31, 2010
Date of Approval:
Not specified
Date of Changes:
Not specified
Year:
2025
Region / City:
Boston, MA, USA
Document Type:
SEC Filing
Issuer:
Aura Biosciences, Inc. [AURA]
Reporting Person:
Amy Elazzouzi
Position:
Senior Vice President, Finance
Transaction Date:
10/29/2025
Security Type:
Common Stock
Transaction Type:
Sale to cover tax withholding on RSUs
Ownership After Transaction:
85,662 shares
Filing Pursuant To:
Section 16(a) of the Securities Exchange Act of 1934
Year:
2025
Region / City:
Washington, D.C., USA
Document Type:
SEC Filing
Organization / Institution:
United States Securities and Exchange Commission
Author:
James Hagedorn
Position:
Chairman & CEO
Issuer:
Scotts Miracle-Gro Co [SMG]
Type of Securities:
Common Stock, Phantom Stock
Transaction Date:
03/26/2025
Filing Date:
03/28/2025
Legal Reference:
Section 16(a) of the Securities Exchange Act of 1934
Signatory:
Kathy L. Uttley as attorney-in-fact